1
|
Le Cann F, Delehouzé C, Leverrier-Penna S, Filliol A, Comte A, Delalande O, Desban N, Baratte B, Gallais I, Piquet-Pellorce C, Faurez F, Bonnet M, Mettey Y, Goekjian P, Samson M, Vandenabeele P, Bach S, Dimanche-Boitrel MT. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis. FEBS J 2017; 284:3050-3068. [PMID: 28715128 DOI: 10.1111/febs.14176] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2017] [Revised: 06/15/2017] [Accepted: 07/13/2017] [Indexed: 12/14/2022]
Abstract
Necroptosis is a regulated form of cell death involved in several disease models including in particular liver diseases. Receptor-interacting protein kinases, RIPK1 and RIPK3, are the main serine/threonine kinases driving this cell death pathway. We screened a noncommercial, kinase-focused chemical library which allowed us to identify Sibiriline as a new inhibitor of necroptosis induced by tumor necrosis factor (TNF) in Fas-associated protein with death domain (FADD)-deficient Jurkat cells. Moreover, Sib inhibits necroptotic cell death induced by various death ligands in human or mouse cells while not protecting from caspase-dependent apoptosis. By using competition binding assay and recombinant kinase assays, we demonstrated that Sib is a rather specific competitive RIPK1 inhibitor. Molecular docking analysis shows that Sib is trapped closed to human RIPK1 adenosine triphosphate-binding site in a relatively hydrophobic pocket locking RIPK1 in an inactive conformation. In agreement with its RIPK1 inhibitory property, Sib inhibits both TNF-induced RIPK1-dependent necroptosis and RIPK1-dependent apoptosis. Finally, Sib protects mice from concanavalin A-induced hepatitis. These results reveal the small-molecule Sib as a new RIPK1 inhibitor potentially of interest for the treatment of immune-dependent hepatitis.
Collapse
Affiliation(s)
- Fabienne Le Cann
- INSERM UMR 1085, l'Environnement et le Travail, Institut de Recherche sur la Santé, Rennes, France.,Biosit UMS 3080, Université de Rennes 1, France
| | - Claire Delehouzé
- UPMC Univ Paris 06, CNRS USR3151, Protein Phosphorylation and Human Disease Laboratory, Sorbonne Universités, Roscoff, France
| | - Sabrina Leverrier-Penna
- INSERM UMR 1085, l'Environnement et le Travail, Institut de Recherche sur la Santé, Rennes, France.,Biosit UMS 3080, Université de Rennes 1, France
| | - Aveline Filliol
- INSERM UMR 1085, l'Environnement et le Travail, Institut de Recherche sur la Santé, Rennes, France.,Biosit UMS 3080, Université de Rennes 1, France
| | - Arnaud Comte
- CNRS UMR 5246, Chimiothèque, ICBMS, Université Claude Bernard Lyon 1, Villeurbanne, France
| | - Olivier Delalande
- CNRS UMR 6290, Institut de Génétique et Développement de Rennes, Université de Rennes 1, France
| | - Nathalie Desban
- UPMC Univ Paris 06, CNRS USR3151, Protein Phosphorylation and Human Disease Laboratory, Sorbonne Universités, Roscoff, France
| | - Blandine Baratte
- UPMC Univ Paris 06, CNRS USR3151, Protein Phosphorylation and Human Disease Laboratory, Sorbonne Universités, Roscoff, France
| | - Isabelle Gallais
- INSERM UMR 1085, l'Environnement et le Travail, Institut de Recherche sur la Santé, Rennes, France.,Biosit UMS 3080, Université de Rennes 1, France
| | - Claire Piquet-Pellorce
- INSERM UMR 1085, l'Environnement et le Travail, Institut de Recherche sur la Santé, Rennes, France.,Biosit UMS 3080, Université de Rennes 1, France
| | - Florence Faurez
- INSERM UMR 1085, l'Environnement et le Travail, Institut de Recherche sur la Santé, Rennes, France.,Biosit UMS 3080, Université de Rennes 1, France
| | - Marion Bonnet
- INSERM UMR 1085, l'Environnement et le Travail, Institut de Recherche sur la Santé, Rennes, France.,Biosit UMS 3080, Université de Rennes 1, France.,Division of Infection & Immunity, College of Biomedical and Life Sciences, Cardiff University, UK
| | - Yvette Mettey
- Laboratoire Chimie Organique, Faculté de Médecine-Pharmacie, Laboratoire Signalisation et Transports Ioniques Membranaires, CNRS, Université de Poitiers, Poitiers Cedex, France
| | - Peter Goekjian
- CNRS UMR 5246, Laboratoire Chimie Organique 2-Glycosciences, ICBMS, Université de Lyon, Université Claude Bernard Lyon 1, Villeurbanne, France
| | - Michel Samson
- INSERM UMR 1085, l'Environnement et le Travail, Institut de Recherche sur la Santé, Rennes, France.,Biosit UMS 3080, Université de Rennes 1, France
| | - Peter Vandenabeele
- Molecular Signaling and Cell Death Unit, VIB Inflammation Research Center, Ghent, Belgium.,Department of Biomedical Molecular Biology, Ghent University, Belgium
| | - Stéphane Bach
- UPMC Univ Paris 06, CNRS USR3151, Protein Phosphorylation and Human Disease Laboratory, Sorbonne Universités, Roscoff, France
| | - Marie-Thérèse Dimanche-Boitrel
- INSERM UMR 1085, l'Environnement et le Travail, Institut de Recherche sur la Santé, Rennes, France.,Biosit UMS 3080, Université de Rennes 1, France
| |
Collapse
|